Financial statements Enbio Technology

Balance sheet of Enbio Technology

Company age:
Age:
21 y. 1 m. 4 d.
Share capital:
Share capital:
710 000 PLN

Balance sheet data of ENBIO TECHNOLOGY

Year
2018
2019
2020
2021
2022
2023
Total assets 16 487 138,02 18 070 129,36 29 449 270,34 42 714 958,00 32 898 223,84 40 747 489,98
A. Fixed assets 2 210 140,39 3 297 446,34 6 551 843,79 4 507 490,02 4 642 162,35 6 756 077,71
B. Current assets 14 276 997,63 14 772 683,02 22 897 426,55 38 207 467,98 28 256 061,49 33 991 412,27
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00 0,00
Total liabilities 16 487 138,02 18 070 129,36 29 449 270,34 42 714 958,00 32 898 223,84 40 747 489,98
A. Equity -16 192 500,28 -25 192 458,16 -30 459 122,44 -40 682 474,37 -43 334 418,71 -32 636 349,52
B. Liabilities and provisions for liabilities 32 679 638,30 43 262 587,52 59 908 392,78 83 397 432,37 76 232 642,55 73 383 839,50
I. Long-term liabilities 8 583 054,85 39 381 821,38 52 689 271,35 62 305 259,71 53 753 734,65 52 783 338,60
II. Short-term liabilities 23 949 401,45 3 833 447,14 6 746 334,85 20 587 803,66 21 980 930,70 19 979 244,90
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.